Replies to post #15002 on DNAprint Genomics (DNAG)

[Grateful]

Robert,

I wondered about that as well. I was going to send the analyst a quick email asking if the Moffitt agreement was left out of the report because it was announced after the report was compiled, or if was left out for some other reason. I’m also curious about whether taking the agreement into account would affect the target pps. (A target of $.06 for this time next year seems conservative to me.)

Also, do you know for certain that the Ovanome trial is already underway? It was supposed to be started by Mar 31, but I’ve seen no official announcement that it was actually started. Did I miss something?

[frogdreaming]

cosmic, Good point.

The analysis seems to predate the Moffit anouncement which took place in late March. I wonder if the 0.06 price goal was based on the pps at that time. In that time frame the pps was in about 4.5 cents, so Dutton's .06 target would amount to a 33% increase after a year. Given today's level of 3.5 cents, should we translate that into a one year target of 4.7 cents. (3.5 x 1.33)?
regards,
frog